Literature DB >> 19193426

Better compliance contributes to better nocturnal continence with orthotopic ileal neobladder than ileocolonic neobladder after radical cystectomy for bladder cancer.

Zhiwen Chen1, Gensheng Lu, Xin Li, Xuemei Li, Qiang Fang, Huixiang Ji, Junan Yan, Zhansong Zhou, Jinhong Pan, Weihua Fu, Weibin Li, Enqing Xiong, Bo Song.   

Abstract

OBJECTIVES: To investigate, in a randomized controlled study, the degree of continence after the creation of orthotopic ileocolonic and ileal neobladders after cystectomy and to explore a possible mechanism for the difference in continence between these 2 types of orthotopic neobladder.
METHODS: From 2003 to 2007, 71 male patients underwent orthotopic lower urinary tract reconstruction with either an ileocolonic or ileal neobladder after radical cystectomy. The degrees of continence and voiding patterns were individually evaluated using urodynamic examinations and a detailed patient questionnaire. The abnormal upper tract was evaluated using intravenous urography and ultrasonography.
RESULTS: Complete daytime continence was achieved in 90.9% and 89.4% of the patients and functional nocturnal continence 48.5% and 76.3% of patients in the ileocolonic neobladder and ileal neobladder groups, respectively. The urodynamic data showed that the initial volume of both the ileocolonic and the ileal neobladder appeared to not be significantly different statistically, although the compliance of the ileocolonic neobladder was lower than that of the ileal neobladder (P < .05). No difference was found in the parameters such as flow rate, urethral profile length, maximal urethral pressure, or neobladder neck pressure between the 2 neobladder types.
CONCLUSIONS: Although the ileocolonic and ileal neobladders can both achieve a large initial volume, the ileal neobladder has an advantage in the aspect of obtaining satisfactory nocturnal continence because of its greater compliance compared with that of the ileocolonic neobladder.

Entities:  

Mesh:

Year:  2009        PMID: 19193426     DOI: 10.1016/j.urology.2008.09.076

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  [Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy].

Authors:  J Kranz; S Schmidt
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

2.  Urodynamic and continence assessment of orthotropic neobladder reconstruction following radical cystectomy in bladder cancer; a prospective, blinded North Indian tertiary care experience.

Authors:  Vishwajeet Singh; Swarnendu Mandal; Sachin Patil; Rahul Janak Sinha; Dheeraj Kumar Gupta; Satya Narayan Sankhwar
Journal:  South Asian J Cancer       Date:  2014-10

Review 3.  Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.

Authors:  June D Cody; Ghulam Nabi; Norman Dublin; Samuel McClinton; David E Neal; Robert Pickard; Sze M Yong
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Orthotopic bladder substitution: Surgical aspects and optimization of outcomes.

Authors:  N Thakare; B W Lamb; S Biers
Journal:  BJUI Compass       Date:  2021-09-02

5.  Long-term urodynamic evaluation of laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer.

Authors:  Dong Wang; Li-Jun Li; Jing Liu; Ming-Xing Qiu
Journal:  Oncol Lett       Date:  2014-06-24       Impact factor: 2.967

6.  Functional outcome of robotic-assisted intracorporeal versus extracorporeal neobladder following radical cystectomy: Initial experience.

Authors:  Altaf Khan; Jeevan Kumar Vuppalapati; Lavanya Raghu Sarath; M Mujeeburahiman; Nischith D'souza
Journal:  Urol Ann       Date:  2021-01-19

7.  Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer - practice in a single centre.

Authors:  Xiaozhou Zhou; Huixiang Ji; Heng Zhang; Tailin Xiong; Jinhong Pan; Zhiwen Chen
Journal:  J Int Med Res       Date:  2018-06-25       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.